Surgery Partners, Inc. (NASDAQ:SGRY) Shares Acquired by First Eagle Investment Management LLC

First Eagle Investment Management LLC grew its stake in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 17.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 292,278 shares of the company's stock after purchasing an additional 43,100 shares during the period. First Eagle Investment Management LLC owned approximately 0.23% of Surgery Partners worth $6,188,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of SGRY. Principal Financial Group Inc. acquired a new position in Surgery Partners during the third quarter worth $1,469,000. State of New Jersey Common Pension Fund D acquired a new position in Surgery Partners during the third quarter worth $1,968,000. Versor Investments LP acquired a new position in Surgery Partners during the third quarter worth $271,000. Victory Capital Management Inc. grew its holdings in Surgery Partners by 140.4% during the third quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company's stock worth $42,892,000 after acquiring an additional 777,038 shares during the period. Finally, KBC Group NV grew its holdings in Surgery Partners by 31.8% during the third quarter. KBC Group NV now owns 2,385 shares of the company's stock worth $77,000 after acquiring an additional 576 shares during the period.

Wall Street Analyst Weigh In

A number of analysts have commented on SGRY shares. Macquarie decreased their target price on Surgery Partners from $34.00 to $33.00 and set an "outperform" rating on the stock in a research report on Tuesday, March 11th. JPMorgan Chase & Co. decreased their target price on Surgery Partners from $38.00 to $28.00 and set a "neutral" rating on the stock in a research report on Tuesday, December 3rd. Royal Bank of Canada decreased their target price on Surgery Partners from $49.00 to $35.00 and set an "outperform" rating on the stock in a research report on Wednesday, November 20th. Finally, Bank of America initiated coverage on Surgery Partners in a research report on Monday, December 16th. They set a "buy" rating and a $30.00 target price on the stock. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, Surgery Partners currently has an average rating of "Moderate Buy" and an average target price of $36.63.

Remove Ads

Surgery Partners Trading Up 0.1 %

Surgery Partners stock traded up $0.03 during trading on Thursday, hitting $24.39. The company's stock had a trading volume of 1,160,598 shares, compared to its average volume of 1,063,140. The stock has a market capitalization of $3.11 billion, a price-to-earnings ratio of -50.81, a P/E/G ratio of 19.21 and a beta of 2.73. The stock's fifty day moving average is $23.79 and its 200 day moving average is $25.88. Surgery Partners, Inc. has a 1-year low of $19.50 and a 1-year high of $33.97. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its earnings results on Monday, March 3rd. The company reported $0.39 EPS for the quarter, beating the consensus estimate of $0.38 by $0.01. The firm had revenue of $864.40 million during the quarter, compared to analyst estimates of $828.09 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. As a group, equities research analysts predict that Surgery Partners, Inc. will post 0.67 EPS for the current year.

Insider Activity at Surgery Partners

In other Surgery Partners news, CFO David T. Doherty sold 6,733 shares of the company's stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $24.02, for a total transaction of $161,726.66. Following the completion of the sale, the chief financial officer now directly owns 150,868 shares in the company, valued at $3,623,849.36. This represents a 4.27 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Jason Eric Evans sold 26,520 shares of the company's stock in a transaction dated Friday, February 7th. The stock was sold at an average price of $25.65, for a total value of $680,238.00. Following the sale, the chief executive officer now owns 560,698 shares of the company's stock, valued at $14,381,903.70. This represents a 4.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 106,622 shares of company stock worth $2,717,860. 2.30% of the stock is currently owned by insiders.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.